According to the differential expression of estrogen receptor (ER), progesterone receptor (PR), and epidermal growth factor receptor type 2 (HER2), breast cancer has been traditionally classified into three different phenotypes: luminal (ER+/PR+), HER2+, and triple-negative breast cancer (TNBC) [2]. This evidence concerns the gene PGR and triple-negative breast carcinoma.